Zydus Lifesciences Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
ZYDUSLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Zydus Lifesciences has submitted a compliance certificate for Q4 FY2026 (ending March 31, 2026) as required under SEBI DP Regulations. The filing confirms that equity share certificates submitted for dematerialization were properly verified, mutilated, and cancelled by the company's Registrar and Transfer Agent, MUFG Intime India Private Limited. The depository has been substituted as the registered owner for these shares. The company also confirms that all securities remain listed on BSE and NSE as required.
This is a routine regulatory compliance filing with no direct impact on shareholders or stock price. It simply confirms the company followed proper procedures for handling share dematerialization requests during the quarter.